Soluble mesothelin neutralizes mesothelin antibody-based therapies.
Katherine E. Smith(Mayo Clinic in Arizona), Aaron S. Mansfield(Mayo Clinic), Paul Dizona(Mayo Clinic in Arizona), Jeffrey L. Winters(Mayo Clinic), Jeffrey A. Moscow(National Cancer Institute), Fabrice Lucien(Université de Sherbrooke), Jacob J. Orme(Mayo Clinic), Yohan Kim(Mayo Clinic in Arizona), Jennifer Ayers-Ringler(Mayo Clinic)
Cited by 2
Related Papers
First-Line Atezolizumab plus Chemotherapy in Extensive-Stage Small-Cell Lung Cancer
|New England Journal of Medicine|2018|3.5k
Detection and localization of surgically resectable cancers with a multi-analyte blood test
|Science|2018|2.8k
Deployment of convalescent plasma for the prevention and treatment of COVID-19
|Journal of Clinical Investigation|2020|863